We are in uncharted territory with COVID 19 and gathering data on what actually renders one high risk, tactics to decrease infection, or decrease infection severity are not really known. Fortunately, reserachers are beginning to gather data that will help us combat this illness. Linked below is a study...
Read More
Coastal Allergy Care is cautiously expanding allergy shot hours. If you haven’t been in for a while you will notice several changes. We continue to check patient temperatures and ask screening questions at the front door. Our staff is also screened by temperature and questions at the start of...
Read More
Dear Valued Patients, During these unprecedented times we want to inform you of the precautions we have implemented to keep you and our staff safe. We are open and are happy to announce that we are available for NEW and ESTABLISHED patients 805-482-8989. We transitioned to Telemedicine and we...
Read More
March 15, 2020 CAC patients- During this time of encouraged Social Distancing CAC has a plan to mitigate crowding in our waiting room. We will begin the process tomorrow, Monday March 16, 2020, and will refine the process as necessary. Coastal Allergy Care will remain open to serve our...
Read More
To our current and future CAC patients- We understand that there is significant concern surrounding the COVID-19 virus. It is clear that we all play a role in protecting each other from spreading the infection. At Coastal Allergy Care we have always followed recommended guidelines to help prevent the...
Read More
Peanut allergy affects about 1 million children in the U.S. Unfortunately, there is still no cure. Allergic individuals must strictly avoid exposure to prevent potentially life threatening reactions. In reality, despite efforts of avoidance, inadvertent exposure can occur. Even exposure to trace amounts can results in symptoms of ranging...
Read More
Gammaglobulin (IVIG and subcutaneous gammaglobulin) is used to treat primary immune deficiency. It is obtained from pooled plasma and takes many donors to get the immunoglobulin necessary to infuse into patients requiring this treatment. In some parts of the country certain brands and types of IVIG have not been...
Read More
If your health insurance has an HSA (healtcare savings account) and you have asthma you may find this very interesting! On July 17, 2019, the Internal Revenue Service (IRS) released guidance (Notice 2019-45) which expands the list of preventive care benefits that health savings account (HSA) insurance products may...
Read More
Dupixent (dupilumab injection) was approved June 26th to treat patients who suffer from chronic nasal polyposis. As you may know, patients living with nasal polyps have a very poor quality of life due to severe nasal congestion, loss of smell and taste. They often go through several surgeries to...
Read More
Another option for injectable epinephrine is set to hit the market this year. Sondoz Pharmaceuticals a division of Novartis has a prefilled epinephrine syrine which should be available in 2019. This device joins epi-pen, epi-pen mylan generic, adrenaclick and AuviQ as treatment for anaphylaxis. Symjepi differs from the current...
Read More